[ET Net News Agency, 5 August 2025] KEYMED BIO-B (02162) rose 10.2% to HK$68.15.
It hits an intra-day high of HK$68.2, hitting a 52-week high, and an intra-day low of
HK$61.95. The total shares traded was 4.57 million, with a value of HK$299.79m. The active
buy/sell ratio is 67:33, with net buying turnover of HK$94.24m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$3.16m, with volume weighted
average price of HK$66.179. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$14.47m, with volume weighted average price of HK$65.534. The stock has
risen a combined 11% over the past 3 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 68.150 % Chg +10.19%
High 68.200 Low 61.950
Shares Tr 4.57m Turnover 299.79m
10-D SMA 62.250 %H.V 62.611
20-D SMA 56.990 VWAP 65.651
50-D SMA 50.344 RSI14 74.302
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 67:33, with net buying turnover
of HK$94.24m, rising a combined 11% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 68.15 +10.19
SINO BIOPHARM (01177) 7.51 +3.59
3SBIO (01530) 32.00 +4.99
EVEREST MED (01952) 69.80 +3.71
ASCENTAGE-B (06855) 82.55 +12.54
SKB BIO-B (06990) 429.00 +6.14
ZAI LAB (09688) 30.92 +4.39
AKESO (09926) 160.90 +5.79
INNOCARE (09969) 19.01 +6.50
REMEGEN (09995) 63.00 +6.51
---------------------------------------------
(ed)